Quercetin-iron chelates are transported via glucose transporters

Free Radical Biology and Medicine

Volumn 50, Issue 8, 2011, Pages 934-944

  Vlachodimitropoulou, Evangelia ^a   Sharp, Paul A ^a   Naftalin, Richard J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Deferiprone; Desferrioxamine; Flavonoids; Free radicals; HaberWeissFenton reaction; Iron chelotherapy; Reactive oxygen species

Indexed keywords

3,6 DIHYDROXYFLAVONE; CATECHOL; CHRYSIN; CYTOCHALASIN B; DEFERIPRONE; DEFEROXAMINE; FERROUS ION; FLAVONE DERIVATIVE; FLAVONONE B; GLUCOSE TRANSPORTER 1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LUTEOLIN; PHLORETIN; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BODY FLUID; CATALYST; CELL COMPARTMENTALIZATION; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DRUG TRANSPORT; HUMAN; HUMAN CELL; IRON CHELATION; IRON OVERLOAD; IRON TRANSPORT; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOCHALASIN B; DEFEROXAMINE; DOGS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; IRON CHELATING AGENTS; PYRIDONES; QUERCETIN; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE;

EID: 79952439249     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.01.005     Document Type: Article

References (54)

1. J.M. McCord Effects of positive iron status at a cellular level Nutr. Rev. 54 1996 85 88 (Pubitemid 26176136)
2. O. Kakhlon, and Z.I. Cabantchik The labile iron pool: characterization, measurement, and participation in cellular processes Free Radic. Biol. Med. 33 2002 1037 1046
3. F. Petrat, H. de Groot, and U. Rauen Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells Biochem. J. 356 2001 61 69 (Pubitemid 34275706)
4. J.F. Goodwin, and C.F. Whitten Chelation of ferrous sulphate solutions by desferrioxamine B Nature 205 1965 281 283
5. S.C. Bischoff Quercetin: potentials in the prevention and therapy of disease Curr. Opin. Clin. Nutr. Metab. Care 11 2008 733 740
6. M. Fiorani, A. Accorsi, and O. Cantoni Human red blood cells as a natural flavonoid reservoir Free Radic. Res. 37 2003 1331 1338 (Pubitemid 37441716)
7. P. Cunningham, I. Afzal-Ahmed, and R.J. Naftalin Docking studies show that D-glucose and quercetin slide through the transporter GLUT1 J. Biol. Chem. 281 2006 5797 5803 (Pubitemid 43847679)
8. P. Strobel, C. Allard, T. Perez-Acle, R. Calderon, R. Aldunate, and F. Leighton Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes Biochem. J. 386 2005 471 478 (Pubitemid 40445871)
9. W.S. Pascoe, K. Inukai, Y. Oka, J.W. Slot, and D.E. James Differential targeting of facilitative glucose transporters in polarized epithelial cells Am. J. Physiol. Cell Physiol. 271 1996 C547 C554
10. M. Hertog, P. Hollman, M. Katan, and D. Kromhout Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands Nutr. Cancer 20 1993 21 29 (Pubitemid 23225364)
11. 4-induced hepatotoxicity in rodents Fitoterapia 73 2002 557 563 (Pubitemid 35477750)
12. X.P. Huang, M. Spino, and J.J. Thiessen Transport kinetics of iron chelators and their chelates in Caco-2 cells Pharm. Res. 23 2006 280 290 (Pubitemid 43237859)
13. S. Wyman, R.J. Simpson, A.T. McKie, and P.A. Sharp Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro FEBS Lett. 582 2008 1901 1906
14. I. Imada, E.F. Sato, M. Miyamoto, Y. Ichimori, Y. Minamiyama, R. Konaka, and M. Inoue Analysis of reactive oxygen species generated by neutrophils using a chemiluminescence probe L-012 Anal. Biochem. 271 1999 53 58 (Pubitemid 29287850)
15. R. Shingles, M. North, and R.E. McCarty Direct measurement of ferrous ion transport across membranes using a sensitive fluorometric assay Anal. Biochem. 296 2001 106 113 (Pubitemid 32808401)
16. A.T. McKie, D. Barrow, G.O. Latunde-Dada, A. Rolfs, G. Sager, E. Mudaly, M. Mudaly, C. Richardson, D. Barlow, A. Bomford, T.J. Peters, K.B. Raja, S. Shirali, M.A. Hediger, F. Farzaneh, and R.J. Simpson An iron-regulated ferric reductase associated with the absorption of dietary iron Science 291 2001 1755 1759 (Pubitemid 32198974)
17. M.L. Guo, C. Perez, Y.B. Wei, E. Rapoza, G. Su, F. Bou-Abdallah, and N.D. Chasteen Iron-binding properties of plant phenolics and cranberrys bio-effects Dalton Trans. 2007 4951 4961 (Pubitemid 350015420)
18. M.T. Fernandez, M.L. Mira, M.H. Florencio, and K.R. Jennings Iron and copper chelation by flavonoids: an electrospray mass spectrometry study J. Inorg. Biochem. 92 2002 105 111 (Pubitemid 35190339)
19. J. Vanderzee, B.B.H. Krootjes, C.F. Chignell, T. Dubbelman, and J. Vansteveninck Hydroxyl radical generation by a light-dependent Fenton reaction Free Radic. Biol. Med. 14 1993 105 113 (Pubitemid 23037066)
20. A. Papadopoulou, R.J. Green, and R.A. Frazier Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study J. Agric. Food Chem. 53 2005 158 163 (Pubitemid 40066484)
21. A. Loban, R. Kime, and H. Powers Iron-binding antioxidant potential of plasma albumin Clin. Sci. (London) 93 1997 445 451 (Pubitemid 27489940)
22. A. Bolli, M. Marino, G. Rimbach, G. Fanali, M. Fasano, and P. Ascenzi Flavonoid binding to human serum albumin Biochem. Biophys. Res. Commun. 398 2010 444 449
23. J.B. Park, and M. Levine Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells J. Nutr. 130 2000 1297 1302 (Pubitemid 30233283)
24. C. Dufour, and O. Dangles Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy Biochim. Biophys. Acta 1721 2005 164 173 (Pubitemid 40093524)
25. P. LeFevre Sugar transport in the red blood cell: structure-activity relationships in substrates and antagonists Pharmacol. Rev. 13 1961 39 70
26. D. Basketter, and W. Widdas Asymmetry of the hexose transfer system in human erythrocytes: comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors J. Physiol. 278 1978 389 401 (Pubitemid 8342390)
27. A. Salas-Burgos, P. Iserovich, F. Zuniga, J. Vera, and J. Fischbarg Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules Biophys. J. 87 2004 2990 2999 (Pubitemid 40468559)
28. E. Cloherty, K. Levine, and A. Carruthers The red blood cell glucose transporter presents multiple, nucleotide-sensitive sugar exit sites Biochemistry 40 2001 15549 15561 (Pubitemid 34015182)
29. M. Comporti, C. Signorini, G. Buonocore, and L. Ciccoli Iron release, oxidative stress and erythrocyte ageing Free Radic. Biol. Med. 32 2002 568 576 (Pubitemid 34241489)
30. C. Hershko, G. Link, A.M. Konijn, and Z.I. Cabantchik Objectives and mechanism of iron chelation therapy Ann. NY Acad. Sci. 1054 2005 124 135 (Pubitemid 43031017)
31. F. Petrat, U. Rauen, and H. de Groot Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, Phen Green SK Hepatology 29 1999 1171 1179 (Pubitemid 29168752)
32. P.V. Browne, O. Shalev, F.A. Kuypers, C. Brugnara, A. Solovey, N. Mohandas, S.L. Schrier, and R.P. Hebbel Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia J. Clin. Invest. 100 1997 1459 1464 (Pubitemid 27425770)
33. J.B. Porter Optimizing iron chelation strategies in beta-thalassaemia major Blood Rev. 23 Suppl. 1 2009 S3 S7
34. P.J. Giardina, and R.W. Grady Chelation therapy in beta-thalassemia: an optimistic update Semin. Hematol. 38 2001 360 366 (Pubitemid 32995605)
35. E. Vlachodimitropoulou, R.J. Naftalin, and P.A. Sharp Quercetin is a substrate for the transmembrane oxidoreductase Dcytb Free Radic. Biol. Med. 48 2010 1366 1369
36. I. Savini, A. Rossi, C. Pierro, L. Avigliano, and M. Catani SVCT1 and SVCT2: key proteins for vitamin C uptake Amino Acids 34 2008 347 355 (Pubitemid 351569766)
37. R. Naftalin, I. Afzal, P. Cunningham, M. Halai, C. Ross, N. Salleh, and S. Milligan Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1 Br. J. Pharmacol. 140 2003 487 499 (Pubitemid 37330493)
38. R. Naftalin, P. Cunningham, and I. Afzal-Ahmed Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport Br. J. Pharmacol. 142 2004 594 608 (Pubitemid 38869874)
39. D. Dwyer The effects of midazolam on the acquisition and expression of fructose- and maltodextrin-based flavour preferences Pharmacol. Biochem. Behav. 91 2009 503 510
40. +/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake J. Pharmacol. Exp. Ther. 322 2007 829 835 (Pubitemid 47105799)
41. Q. Wang, and M. Morris Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo Drug Metab. Dispos. 35 2007 201 208 (Pubitemid 46151668)
42. C.P. Wu, A. Klokouzas, S.B. Hladky, S.V. Ambudkar, and M.A. Barrand Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes Biochem. Pharmacol. 70 2005 500 510 (Pubitemid 40978539)
43. A. Sen, and W. Widdas Variations of the parameters of glucose transfer across the human erythrocyte membrane in the presence of inhibitors of transfer J. Physiol. 160 1962 404 416
44. P. Ader, M. Blöck, S. Pietzsch, and S. Wolffram Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1) Cancer Lett. 162 2001 175 180 (Pubitemid 32056286)
45. R.W. Grady, V.A. Berdoukas, and P.J. Giardina Iron chelation: combined therapy could be a better approach Blood 92 1998 3046
46. R.C. Hider, and Z.D. Liu Emerging understanding of the advantage of small molecules such as hydroxypyridinones in the treatment of iron overload Curr. Med. Chem. 10 2003 1051 1064 (Pubitemid 36582248)
47. C. Hershko, G. Link, A.M. Konijn, and Z.I. Cabantchik Objectives and mechanism of iron chelation therapy Cooleys Anemia Eighth Symp. 1054 2005 124 135 (Pubitemid 43031017)
48. M. Ferrali, C. Signorini, B. Caciotti, L. Sugherini, L. Ciccoli, D. Giachetti, and M. Comporti Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity FEBS Lett. 416 1997 123 129 (Pubitemid 27462770)
49. G.A. Barber Enzymic glycosylation of quercetin to rutin Biochemistry 1 1962 463 468
50. R.J. Williams, J.P. Spencer, and C. Rice-Evans Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med. 36 2004 838 849 (Pubitemid 38352901)
51. Y. Lee, H. Huang, C. Chang, C. Cheng, and Y. Chen Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome Hum. Mol. Genet. 19 2010 3721 3733
52. I. Erlund, R. Freese, J. Marniemi, P. Hakala, and G. Alfthan Bioavailability of quercetin from berries and the diet Nutr. Cancer 54 2006 13 17 (Pubitemid 44141332)
53. A. Shanzer, J. Libman, S. Lytton, H. Glickstein, and Z. Cabantchik Reversed siderophores act as antimalarial agents Proc. Natl Acad. Sci. USA 88 1991 6585 6589 (Pubitemid 21914992)
54. I. Afzal-Ahmed, G. Mann, A. Shennan, L. Poston, and R. Naftalin Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells Free Radic. Biol. Med. 42 2007 1781 1790 (Pubitemid 46754755)